Terns Pharmaceuticals

1D
1W
1M
3M
1Y
5Y

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell TERN and other ETFs, options, and stocks.

About TERN

Terns Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company, which engages in developing a portfolio of small-molecule single-agent and combination therapy candidates for the treatment of non-alcoholic steatohepatitis, or NASH, and other chronic liver diseases. The firm's pipeline includes clinical stage development programs, including a FXR agonist, a VAP-1 inhibitor, a THR-ß agonist, and a preclinical GLP-1 receptor agonist program. 

CEO
Senthil Sundaram
CEOSenthil Sundaram
Employees
41
Employees41
Headquarters
Foster City, California
HeadquartersFoster City, California
Founded
2017
Founded2017
Employees
41
Employees41

TERN Key Statistics

Market cap
238.85M
Market cap238.85M
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
154.26K
Average volume154.26K
High today
$6.45
High today$6.45
Low today
$5.60
Low today$5.60
Open price
$6.15
Open price$6.15
Volume
237.98K
Volume237.98K
52 Week high
$10.72
52 Week high$10.72
52 Week low
$1.45
52 Week low$1.45

TERN Earnings

-$0.88
-$0.59
-$0.29
$0.00
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Estimated
per share
Estimated per share
Actual
Expected Nov 14, Pre-Market
ActualExpected Nov 14, Pre-Market
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, a registered broker-dealer and Member SIPC.